Philippe Soubrié

Overview

Best Publications

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  Murielle Rinaldi-Carmona;Francis Barth;Michel Héaulme;David Shire

  2697
  Citations

• Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

  M Arnone;J Maruani;F Chaperon;M H Thiébot

  932
  Citations

• The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

  M. Bensaid;M. Gary-Bobo;A. Esclangon;J. P. Maffrand

  927
  Citations

• Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

  Christine Ravinet Trillou;Michèle Arnone;Claire Delgorge;Nadine Gonalons

  838
  Citations

• CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.

  C Ravinet Trillou;C Delgorge;C Menet;M Arnone

  824
  Citations

• Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

  Guy Griebel;Jacques Simiand;Claudine Serradeil-Le Gal;Jean Wagnon

  676
  Citations

• SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.

  C. Cohen;G. Perrault;C. Voltz;R. Steinberg

  566
  Citations

• In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

  Xavier Emonds-Alt;Jean-Daniel Doutremepuich;Michel Heaulme;Gervais Neliat

  551
  Citations

• The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

  Omar Jbilo;Christine Ravinet-Trillou;Michèle Arnone;Isabelle Buisson

  498
  Citations

• Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

  J. P. Terranova;J. J. Storme;N. Lafon;A Pério

  425
  Citations

• Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

  Magali Gary-Bobo;Ghizlane Elachouri;Jean François Gallas;Philip Janiak

  424
  Citations

• SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

  Simiand J;Keane M;Keane Pe;Soubrié P

  415
  Citations

• Blockade of CRF 1 or V 1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

  R Alonso;G Griebel;G Pavone;J Stemmelin

  412
  Citations

• Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

  Frédérique Chaperon;Philippe Soubrié;Alain J. Puech;Marie-Hélène Thiébot

  407
  Citations

• Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

  Murielle Rinaldi-Carmona;Francis Barth;Michel Héaulme;Richard Alonso

  400
  Citations

• Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

  Caroline Cohen;Ghislaine Perrault;Guy Griebel;Philippe Soubrié

  362
  Citations

• 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-((1S)-2-cyclopropyl- 1-(3-fluoro-4-methylphenyl)ethyl)5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor 1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders

  Guy Griebel;Jacques Simiand;Régis Steinberg;Mireille Jung

  336
  Citations

• Characterization of (2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

  Claudine Serradeil-Le Gal;Jean Wagnon;Jacques Simiand;Guy Griebel

  320
  Citations

• SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptor

  X. Emonds-Alt;D. Bichon;J.P. Ducoux;M. Heaulme

  300
  Citations

• Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.

  Terranova Jp;Michaud Jc;Le Fur G;Soubrié P

  296
  Citations